ウシ呼吸器疾患治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Bovine Respiratory Disease Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8100801)・商品コード:GIR8100801
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月19日(※2024年版があります。お問い合わせください)
・ページ数:137
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、ウシ呼吸器疾患治療の世界市場について調べ、まとめました。種類別セグメントは、ワクチン、抗生物質、免疫調節剤、その他等、用途別セグメントは、獣医診療所、獣医病院、獣医学研究所、私立獣医学薬局等に区分しました。ウシ呼吸器疾患治療の世界市場概観、メーカー動向、メーカー別ウシ呼吸器疾患治療シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・ウシ呼吸器疾患治療の市場概観
・ウシ呼吸器疾患治療のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・ウシ呼吸器疾患治療のメーカー別販売動向、市場シェア、市場集中度、競争動向
・ウシ呼吸器疾患治療の世界市場規模
・ウシ呼吸器疾患治療の北米市場分析(アメリカ、カナダ、メキシコ等)
・ウシ呼吸器疾患治療のアメリカ市場規模推移
・ウシ呼吸器疾患治療のカナダ市場規模推移
・ウシ呼吸器疾患治療のメキシコ市場規模推移
・ウシ呼吸器疾患治療のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・ウシ呼吸器疾患治療のドイツ市場規模推移
・ウシ呼吸器疾患治療のイギリス市場規模推移
・ウシ呼吸器疾患治療のロシア市場規模推移
・ウシ呼吸器疾患治療のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・ウシ呼吸器疾患治療の日本市場規模推移
・ウシ呼吸器疾患治療の中国市場規模推移
・ウシ呼吸器疾患治療の韓国市場規模推移
・ウシ呼吸器疾患治療のインド市場規模推移
・ウシ呼吸器疾患治療の東南アジア市場規模推移
・ウシ呼吸器疾患治療の南米市場分析(ブラジル、アルゼンチン等)
・ウシ呼吸器疾患治療の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・ウシ呼吸器疾患治療の種類別分析/市場規模推移(ワクチン、抗生物質、免疫調節剤、その他)
・ウシ呼吸器疾患治療の用途別分析/市場規模推移(獣医診療所、獣医病院、獣医学研究所、私立獣医学薬局)
・ウシ呼吸器疾患治療の市場予測(地域別予測、種類別予測、用途別予測)
・ウシ呼吸器疾患治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites. However, due to increasing consumption of milk and beef products, the need for bovine respiratory disease treatment has increased across the globe.

Scope of the Report:

This report studies the Bovine Respiratory Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bovine Respiratory Disease Treatment market by product type and applications/end industries.

One of the major factors responsible for the market’s growth is the increasing interests of several vendors on the development of novel drugs to gain a competitive advantage over their competitors. For instance, Bayer HealthCare launched Zelnate in the US, which is a bacterial-produced plasmid DNA including a liposome carrier that helps to stimulate the innate immune system in cattle. Furthermore, under traditional antibiotics segment also, vendors are launching various drugs such as draxxin for the cattle respiratory disease treatment. The growing focus on the development of combination drugs will drive the growth prospects for the global BRD treatment market for the next few years. Some of the major factors responsible for the growing number of development of combination drugs is the need to offer improved efficacy and ensure better treatment outcomes.

North America accounts for a major share in the global market, of which around 90% is held by the U.S. alone. The bovine respiratory disease treatment market in the U.S. is propelled by the rising domestic production, consumption, and export of bovine meat.

The global Bovine Respiratory Disease Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bovine Respiratory Disease Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Bayer HealthCare

Boehringer Ingelheim

Elanco

Merck

Zoetis

Ceva

Inovio Pharmaceuticals

Norbrook Laboratories

Plumbline Life Sciences

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Vaccines

Antibiotics

Immunomodulators

Others

Market Segment by Applications, can be divided into

Veterinary Clinics

Veterinary Hospitals

Veterinary Research Institutes

Private Veterinary Pharmacies

【レポートの目次】

Table of Contents

1 Bovine Respiratory Disease Treatment Market Overview

1.1 Product Overview and Scope of Bovine Respiratory Disease Treatment

1.2 Classification of Bovine Respiratory Disease Treatment by Types

1.2.1 Global Bovine Respiratory Disease Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Bovine Respiratory Disease Treatment Revenue Market Share by Types in 2017

1.2.3 Vaccines

1.2.4 Antibiotics

1.2.5 Immunomodulators

1.2.6 Others

1.3 Global Bovine Respiratory Disease Treatment Market by Application

1.3.1 Global Bovine Respiratory Disease Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Veterinary Clinics

1.3.3 Veterinary Hospitals

1.3.4 Veterinary Research Institutes

1.3.5 Private Veterinary Pharmacies

1.4 Global Bovine Respiratory Disease Treatment Market by Regions

1.4.1 Global Bovine Respiratory Disease Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Bovine Respiratory Disease Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Bayer HealthCare

2.1.1 Business Overview

2.1.2 Bovine Respiratory Disease Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bayer HealthCare Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Boehringer Ingelheim

2.2.1 Business Overview

2.2.2 Bovine Respiratory Disease Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Boehringer Ingelheim Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Elanco

2.3.1 Business Overview

2.3.2 Bovine Respiratory Disease Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Elanco Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Merck

2.4.1 Business Overview

2.4.2 Bovine Respiratory Disease Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merck Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 Zoetis

2.5.1 Business Overview

2.5.2 Bovine Respiratory Disease Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Zoetis Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 Ceva

2.6.1 Business Overview

2.6.2 Bovine Respiratory Disease Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Ceva Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.7 Inovio Pharmaceuticals

2.7.1 Business Overview

2.7.2 Bovine Respiratory Disease Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Inovio Pharmaceuticals Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.8 Norbrook Laboratories

2.8.1 Business Overview

2.8.2 Bovine Respiratory Disease Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Norbrook Laboratories Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.9 Plumbline Life Sciences

2.9.1 Business Overview

2.9.2 Bovine Respiratory Disease Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Plumbline Life Sciences Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Bovine Respiratory Disease Treatment Market Competition, by Players

3.1 Global Bovine Respiratory Disease Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Bovine Respiratory Disease Treatment Players Market Share

3.2.2 Top 10 Bovine Respiratory Disease Treatment Players Market Share

3.3 Market Competition Trend

4 Global Bovine Respiratory Disease Treatment Market Size by Regions

4.1 Global Bovine Respiratory Disease Treatment Revenue and Market Share by Regions

4.2 North America Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

5 North America Bovine Respiratory Disease Treatment Revenue by Countries

5.1 North America Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)

5.2 USA Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

6 Europe Bovine Respiratory Disease Treatment Revenue by Countries

6.1 Europe Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)

6.2 Germany Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

6.4 France Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Bovine Respiratory Disease Treatment Revenue by Countries

7.1 Asia-Pacific Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)

7.2 China Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

7.5 India Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

8 South America Bovine Respiratory Disease Treatment Revenue by Countries

8.1 South America Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)

8.2 Brazil Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Bovine Respiratory Disease Treatment by Countries

9.1 Middle East and Africa Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

10 Global Bovine Respiratory Disease Treatment Market Segment by Type

10.1 Global Bovine Respiratory Disease Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Bovine Respiratory Disease Treatment Market Forecast by Type (2018-2023)

10.3 Vaccines Revenue Growth Rate (2013-2023)

10.4 Antibiotics Revenue Growth Rate (2013-2023)

10.5 Immunomodulators Revenue Growth Rate (2013-2023)

10.6 Others Revenue Growth Rate (2013-2023)

11 Global Bovine Respiratory Disease Treatment Market Segment by Application

11.1 Global Bovine Respiratory Disease Treatment Revenue Market Share by Application (2013-2018)

11.2 Bovine Respiratory Disease Treatment Market Forecast by Application (2018-2023)

11.3 Veterinary Clinics Revenue Growth (2013-2018)

11.4 Veterinary Hospitals Revenue Growth (2013-2018)

11.5 Veterinary Research Institutes Revenue Growth (2013-2018)

11.6 Private Veterinary Pharmacies Revenue Growth (2013-2018)

12 Global Bovine Respiratory Disease Treatment Market Size Forecast (2018-2023)

12.1 Global Bovine Respiratory Disease Treatment Market Size Forecast (2018-2023)

12.2 Global Bovine Respiratory Disease Treatment Market Forecast by Regions (2018-2023)

12.3 North America Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)

12.6 South America Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Bovine Respiratory Disease Treatment Picture

Table Product Specifications of Bovine Respiratory Disease Treatment

Table Global Bovine Respiratory Disease Treatment and Revenue (Million USD) Market Split by Product Type

Figure Global Bovine Respiratory Disease Treatment Revenue Market Share by Types in 2017

Figure Vaccines Picture

Figure Antibiotics Picture

Figure Immunomodulators Picture

Figure Others Picture

Table Global Bovine Respiratory Disease Treatment Revenue (Million USD) by Application (2013-2023)

Figure Bovine Respiratory Disease Treatment Revenue Market Share by Applications in 2017

Figure Veterinary Clinics Picture

Figure Veterinary Hospitals Picture

Figure Veterinary Research Institutes Picture

Figure Private Veterinary Pharmacies Picture

Table Global Market Bovine Respiratory Disease Treatment Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Bovine Respiratory Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Bovine Respiratory Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Bovine Respiratory Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Bovine Respiratory Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Bovine Respiratory Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Bovine Respiratory Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Table Bayer HealthCare Basic Information, Manufacturing Base and Competitors

Table Bayer HealthCare Bovine Respiratory Disease Treatment Type and Applications

Table Bayer HealthCare Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors

Table Boehringer Ingelheim Bovine Respiratory Disease Treatment Type and Applications

Table Boehringer Ingelheim Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Elanco Basic Information, Manufacturing Base and Competitors

Table Elanco Bovine Respiratory Disease Treatment Type and Applications

Table Elanco Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Bovine Respiratory Disease Treatment Type and Applications

Table Merck Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Zoetis Basic Information, Manufacturing Base and Competitors

Table Zoetis Bovine Respiratory Disease Treatment Type and Applications

Table Zoetis Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Ceva Basic Information, Manufacturing Base and Competitors

Table Ceva Bovine Respiratory Disease Treatment Type and Applications

Table Ceva Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Inovio Pharmaceuticals Bovine Respiratory Disease Treatment Type and Applications

Table Inovio Pharmaceuticals Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Norbrook Laboratories Basic Information, Manufacturing Base and Competitors

Table Norbrook Laboratories Bovine Respiratory Disease Treatment Type and Applications

Table Norbrook Laboratories Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Plumbline Life Sciences Basic Information, Manufacturing Base and Competitors

Table Plumbline Life Sciences Bovine Respiratory Disease Treatment Type and Applications

Table Plumbline Life Sciences Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Global Bovine Respiratory Disease Treatment Revenue (Million USD) by Players (2013-2018)

Table Global Bovine Respiratory Disease Treatment Revenue Share by Players (2013-2018)

Figure Global Bovine Respiratory Disease Treatment Revenue Share by Players in 2016

Figure Global Bovine Respiratory Disease Treatment Revenue Share by Players in 2017

Figure Global Top 5 Players Bovine Respiratory Disease Treatment Revenue Market Share in 2017

Figure Global Top 10 Players Bovine Respiratory Disease Treatment Revenue Market Share in 2017

Figure Global Bovine Respiratory Disease Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Bovine Respiratory Disease Treatment Revenue (Million USD) by Regions (2013-2018)

Table Global Bovine Respiratory Disease Treatment Revenue Market Share by Regions (2013-2018)

Figure Global Bovine Respiratory Disease Treatment Revenue Market Share by Regions (2013-2018)

Figure Global Bovine Respiratory Disease Treatment Revenue Market Share by Regions in 2017

Figure North America Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Europe Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure South America Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Table North America Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)

Table North America Bovine Respiratory Disease Treatment Revenue Market Share by Countries (2013-2018)

Figure North America Bovine Respiratory Disease Treatment Revenue Market Share by Countries (2013-2018)

Figure North America Bovine Respiratory Disease Treatment Revenue Market Share by Countries in 2017

Figure USA Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Canada Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Mexico Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Table Europe Bovine Respiratory Disease Treatment Revenue (Million USD) by Countries (2013-2018)

Figure Europe Bovine Respiratory Disease Treatment Revenue Market Share by Countries (2013-2018)

Figure Europe Bovine Respiratory Disease Treatment Revenue Market Share by Countries in 2017

Figure Germany Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure UK Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure France Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Russia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Italy Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Bovine Respiratory Disease Treatment Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Bovine Respiratory Disease Treatment Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Bovine Respiratory Disease Treatment Revenue Market Share by Countries in 2017

Figure China Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Japan Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Korea Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure India Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Table South America Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)

Table South America Bovine Respiratory Disease Treatment Revenue Market Share by Countries (2013-2018)

Figure South America Bovine Respiratory Disease Treatment Revenue Market Share by Countries (2013-2018)

Figure South America Bovine Respiratory Disease Treatment Revenue Market Share by Countries in 2017

Figure Brazil Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Argentina Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Colombia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Bovine Respiratory Disease Treatment Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Bovine Respiratory Disease Treatment Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Bovine Respiratory Disease Treatment Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Bovine Respiratory Disease Treatment Revenue Market Share by Countries in 2017

Figure Saudi Arabia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure UAE Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Egypt Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure Nigeria Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Figure South Africa Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)

Table Global Bovine Respiratory Disease Treatment Revenue (Million USD) by Type (2013-2018)

Table Global Bovine Respiratory Disease Treatment Revenue Share by Type (2013-2018)

Figure Global Bovine Respiratory Disease Treatment Revenue Share by Type (2013-2018)

Figure Global Bovine Respiratory Disease Treatment Revenue Share by Type in 2017

Table Global Bovine Respiratory Disease Treatment Revenue Forecast by Type (2018-2023)

Figure Global Bovine Respiratory Disease Treatment Market Share Forecast by Type (2018-2023)

Figure Global Vaccines Revenue Growth Rate (2013-2018)

Figure Global Antibiotics Revenue Growth Rate (2013-2018)

Figure Global Immunomodulators Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Table Global Bovine Respiratory Disease Treatment Revenue by Application (2013-2018)

Table Global Bovine Respiratory Disease Treatment Revenue Share by Application (2013-2018)

Figure Global Bovine Respiratory Disease Treatment Revenue Share by Application (2013-2018)

Figure Global Bovine Respiratory Disease Treatment Revenue Share by Application in 2017

Table Global Bovine Respiratory Disease Treatment Revenue Forecast by Application (2018-2023)

Figure Global Bovine Respiratory Disease Treatment Market Share Forecast by Application (2018-2023)

Figure Global Veterinary Clinics Revenue Growth Rate (2013-2018)

Figure Global Veterinary Hospitals Revenue Growth Rate (2013-2018)

Figure Global Veterinary Research Institutes Revenue Growth Rate (2013-2018)

Figure Global Private Veterinary Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Bovine Respiratory Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Bovine Respiratory Disease Treatment Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Bovine Respiratory Disease Treatment Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)

Figure Europe Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)

Figure South America Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)



【レポートのキーワード】

ウシ呼吸器疾患治療、ワクチン、抗生物質、免疫調節剤、その他、獣医診療所、獣医病院、獣医学研究所、私立獣医学薬局

★調査レポート[ウシ呼吸器疾患治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8100801)販売に関する免責事項を必ずご確認ください。
★調査レポート[ウシ呼吸器疾患治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆